Saturday, September 23, 2023
Saturday, September 23, 2023

FX Solutions, SAS. and FX Shoulder, Inc. to Merge into FX

FX Solutions was founded in 2011 in Viriat, France, and there has always been a vision and passion to grow the portfolio to become a major global competitor. With its start in France, they quickly expanded their market presence throughout Europe.

In 2017, FX Solutions was acquired by Ekkio Capital (Paris, FR). This was the driving force to begin expansion into an extremely competitive US market. FX Shoulder USA was launched as a subsidiary of FX Solutions and quickly grew their footprint in the US Market. With many recent changes and innovations in the US, FX Shoulder has become one of the fastest growing and most innovative companies in its market segment. This was done by staying hyper-focused on shoulder arthroplasty—a market segment that continues to grow at an aggressive pace with constant innovation that allows surgeons even more solutions to care for patients.

“With a complete portfolio and with constant innovation, the time is now to join our two companies as one identity on the global stage,” said, Baptiste Martin, CEO of FX. “This will allow us to streamline our efforts and move as one team with one common goal—to grow our portfolio and market share globally with several key areas of opportunity.”

FX Shoulder USA, Inc. is the direct provider of FX Solutions shoulder replacement devices in the US. FX Solutions will continue to provide the portfolio and sales efforts worldwide (OUS). Both will now be branded as one company [FX] with a US Headquarters in Dallas, and a Global Headquarters in Viriat, France.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Summus Raises $19.5 Million

Fundraise supports market expansion with Summus emerging as the premier clinical platform to share and access high quality specialty expertise across the continuum of care — serving employers, payers, health systems and physician groups.

Thirona Raises €7,5 Million New Financing to Accelerate the Adoption of its Breakthrough Innovations for Precision Medicine

With this financing, Thirona plans to accelerate the adoption of its break-through innovations for precision medicine.

Levee Medical Secures $4.3M Strategic Investment to Accelerate Clinical Development of the Voro Urologic Scaffold, Designed to Improve Robotic Prostatectomy Outcomes

The trial will evaluate the safety and performance of the Voro Urologic Scaffold as a prophylactic treatment for post-prostatectomy stress urinary incontinence, notes Levee Medical.

Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities

The funding represents a strong endorsement of Innovac's technology, mission and vision from a range of industry Investors.

TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration

Dr Anandkumar Nandakumar, CEO of TherageniX, commented: “Our mission is to advance treatments in repairing tissue damage and we are grateful for the support from Innovate UK at this early stage. This grant is a testament to the potential of TherageniX’s novel approach to tissue regeneration and will enable us to make great strides in manufacturing our powdered gene therapy.

By using this website you agree to accept Medical Device News Magazine Privacy Policy